Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial.
Andrea Natale, Sanghamitra Mohanty, P Y Liu...
https://pubmed.ncbi.nlm.nih.gov/31971899Actively Recruiting
Led by Kansas City Heart Rhythm Research Foundation · Updated on 2024-10-29
110
Participants Needed
6
Research Sites
N/A
Total Duration
This research aims to evaluate the effectiveness of the LockeT device for achieving hemostasis after venous procedures compared to the current standard method of Manual Compression (MC). The study focuses on patients undergoing catheter ablation for atrial fibrillation and other arrhythmias, where vascular closure following large-bore sheath femoral access remains challenging. The trial is prospective, randomized, and conducted at a single center, enrolling around 110 patients. Participants are randomly assigned to one of two groups: the LockeT device group or the Manual Compression group. In the LockeT group, a healthcare professional places the LockeT device with suture above the wound to apply compression, aiming to mimic manual pressure but without continuous bedside presence. After hemostasis is achieved and before walking, the device and sutures are removed. The Manual Compression group receives the standard care of manual pressure to close the access site wound. During the study, researchers will assess the effectiveness of the LockeT device within 2 days following the procedure. They will also evaluate benefits to patients, physicians, and nursing staff, measure patient discomfort, track hematoma or bruising incidence, monitor safety, and compare labor and device costs. Participants will be closely monitored during this short follow-up period to understand outcomes related to vascular closure methods.
CONDITIONS
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 2 days
Participants undergo vascular closure using either the LockeT suture retention device or manual compression after atrial fibrillation ablation.
1 procedure visit and 1 device removal visit
Total: 6 locations
1
Kansas City Heart Rhythm Institute - Roe Clinic
Overland Park, Kansas, United States, 66211
Actively Recruiting
2
Overland Park Regional Medical Center
Overland Park, Kansas, United States, 66215
Actively Recruiting
3
Centerpoint Medical Center Clinic
Independence, Missouri, United States, 64057
Actively Recruiting
4
Centerpoint Medical Center
Independence, Missouri, United States, 64057
Actively Recruiting
5
Research Medical Center Clinic
Kansas City, Missouri, United States, 64032
Actively Recruiting
6
Research Medical Center
Kansas City, Missouri, United States, 64032
Actively Recruiting
D
Donita Atkins
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Andrea Natale, Sanghamitra Mohanty, P Y Liu...
https://pubmed.ncbi.nlm.nih.gov/31971899Mark Terence Mujer, Abdullah Al-Abcha, Jairus Flores...
https://pubmed.ncbi.nlm.nih.gov/32638389Varunsiri Atti, Mohit K Turagam, Jalaj Garg...
https://pubmed.ncbi.nlm.nih.gov/31001767Christoph J Jensen, Miriam Schnur, Sebastian Lask...
https://pubmed.ncbi.nlm.nih.gov/32308550